药物相关的病:一个药监测研究
Qi Wang1, Jun Ling Zhuang1, Bing Han1
1Department of Hematology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Orphanet journal of rare diseases
|August 1, 2024
概括
识别引发病发作的药物对于患者的安全至关重要. 这项研究分析了不良事件报告,以确定52种与症相关的药物,帮助携带者获得更安全的处方做法.
科学领域:
- 药物监督 药物监督 药物监督
- 药品安全 药品安全
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 病发作,可能是致命的,是由类药物引起的.
- 评估症携带者的药物安全性是一个重大的临床挑战.
研究的目的:
- 使用大型不良事件数据库识别与病相关的药物.
- 为临床决策提供关于药物氧化剂的关键信息.
主要方法:
- 美国食品和药物管理局的不良事件报告系统 (FAERS) 数据 (2004-2022) 的回顾性分析.
- 利用四个信号挖掘算法来检测药物和病不良事件之间的关联.
- 选了406种药物,使用特定的搜索术语与症相关.
主要成果:
- 在FAERS报告中,报告了1470例与症相关的不良事件.
- 在所有四种算法中,52种药物被确定为具有与病相关的显著信号.
- 详细分析了报告的病例和确定的药物的特征.
结论:
- 这项研究是第一个使用全面数据分析报告与药物相关的形症的研究.
- 这些发现有助于合理的,基于证据的药物处方,并改善射性预测.
- 为临床医生提供了一个关键的参考,以避免对症突变携带者开处方类药物.
相关概念视频
Pharmacovigilance
805
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
805
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
110
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
110
Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
Drug Metabolism: Phase I Reactions
3.2K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.2K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
125
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
125
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
36
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
36


